ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BCTX BriaCell Therapeutics Corporation

2.26
0.02 (0.89%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BriaCell Therapeutics Corporation BCTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.02 0.89% 2.26 08:00:04
Open Price Low Price High Price Close Price Previous Close
2.25 2.23 2.34 2.26 2.24
more quote information »

Recent News

Date Time Source Heading
24/4/202422:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/4/202422:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/4/202422:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
08/3/202400:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
07/3/202400:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
28/2/202400:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
08/2/202400:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
07/2/202400:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
01/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
01/2/202409:24EDGAR2Form 8-K - Current report
31/1/202414:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
23/1/202409:00EDGAR2Form S-3 - Registration statement under Securities Act of..
10/1/202408:05EDGAR2Form DEF 14A - Other definitive proxy statements
05/1/202400:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
29/12/202300:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
21/12/202308:05EDGAR2Form 8-K - Current report
21/12/202300:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
15/12/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/12/202309:00EDGAR2Form 8-K - Current report
07/12/202301:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
07/12/202301:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
30/11/202323:00EDGAR2Form 8-K - Current report
30/11/202323:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
03/11/202323:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
26/10/202300:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
21/10/202300:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
19/10/202300:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
12/10/202300:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
05/10/202300:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
04/10/202300:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
08/9/202321:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
01/9/202301:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
31/8/202322:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
26/8/202304:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
19/8/202302:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
16/8/202322:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
27/6/202323:37APSNews Brief: BriaCell Therapeutics Corp.
27/6/202322:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..
25/5/202323:00GLOBEBriaCell Enters Definitive Arrangement Agreement for the..
20/5/202301:38GLOBEBriaCell Closes $4 Million Strategic Investment by Prevail..
15/5/202322:00GLOBEBriaCell Announces $4 Million Strategic Investment and..

Your Recent History

Delayed Upgrade Clock